Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2571 Pepstatin A9 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
A3966 Doxorubicin36 CitationSummary: DNA topoisomerase II inhibitor -
A4393 Paclitaxel (Taxol)28 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor -
A8487 Nocodazole8 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A8627 Bafilomycin A131 CitationSummary: V-ATPases inhibitor -
A2585 MG-132127 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A2614 Bortezomib (PS-341)53 CitationTarget: ProteasomeSummary: proteasome inhibitor -
B6107 ML241Summary: p97 ATPase inhibitor -
B6122 ML241 hydrochlorideSummary: p97 ATPase inhibitor -
B6160 PIK-III1 CitationSummary: VPS34 inhibitor and inhibits autophagy

